|
| 37046379 | Diffuse Pediatric-type High-grade Glioma Arising in an Ovarian Mature Cystic Teratoma. | Int J Gynecol Pathol | 2024 |
| 37921028 | Assessment of The Utility of The Sarcoma DNA Methylation Classifier In Surgical Pathology. | Am J Surg Pathol | 2024 |
| 37899499 | Utility of Immunohistochemistry With Antibodies to SS18-SSX Chimeric Proteins and C-Terminus of SSX Protein for Synovial Sarcoma Differential Diagnosis. | Am J Surg Pathol | 2024 |
| 37870438 | Impact of Rare and Multiple Concurrent Gene Fusions on Diagnostic DNA Methylation Classifier in Brain Tumors. | Mol Cancer Res | 2024 |
| 37046379 | Diffuse Pediatric-type High-grade Glioma Arising in an Ovarian Mature Cystic Teratoma. | Int J Gynecol Pathol | 2024 |
| 37899499 | Utility of Immunohistochemistry With Antibodies to SS18-SSX Chimeric Proteins and C-Terminus of SSX Protein for Synovial Sarcoma Differential Diagnosis. | Am J Surg Pathol | 2024 |
| 37921028 | Assessment of The Utility of The Sarcoma DNA Methylation Classifier In Surgical Pathology. | Am J Surg Pathol | 2024 |
| 37870438 | Impact of Rare and Multiple Concurrent Gene Fusions on Diagnostic DNA Methylation Classifier in Brain Tumors. | Mol Cancer Res | 2024 |
| 35976058 | Docetaxel targets aggressive methylation profiles and serves as a radiosensitizer in high-risk meningiomas. | Neuro Oncol | 2023 |
| 35976058 | Docetaxel targets aggressive methylation profiles and serves as a radiosensitizer in high-risk meningiomas. | Neuro Oncol | 2023 |
| 35849035 | Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial. | Neuro Oncol | 2023 |
| 36271929 | Expanded analysis of high-grade astrocytoma with piloid features identifies an epigenetically and clinically distinct subtype associated with neurofibromatosis type 1. | Acta Neuropathol | 2023 |
| 37851269 | Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations. | Acta Neuropathol | 2023 |
| 38026572 | Reference on copy number variations in pleomorphic xanthoastrocytoma: Implications for diagnostic approach. | Free Neuropathol | 2023 |
| 37742132 | A novel ARIH1::BRAF fusion in a glioma. | J Neuropathol Exp Neurol | 2023 |
| 37790315 | Prediction of cancer treatment response from histopathology images through imputed transcriptomics. | Res Sq | 2023 |
| 37953374 | Pseudoendocrine sarcoma: clinicopathologic, molecular, and epigenetic features of one case. | Virchows Arch | 2023 |
| 37345354 | NCI intramural program approach to rare tumors: Natural history study of rare solid tumors in children and adults: A longitudinal, comprehensive data and biospecimen collection protocol. | Pediatr Blood Cancer | 2023 |
| 37287579 | Introduction: Ongoing clinical challenges in the management of meningiomas and future directions. | Neurooncol Adv | 2023 |
| 37218333 | ZFTA-fused supratentorial ependymoma with a novel fusion partner, DUX4. | J Neuropathol Exp Neurol | 2023 |
| 36840836 | The multiomic landscape of meningiomas: a review and update. | J Neurooncol | 2023 |
| 36655517 | First-time identification of a KIF5B-NTRK2 fusion in extraventricular neurocytoma. | J Neuropathol Exp Neurol | 2023 |
| 37474126 | Integrated molecular analysis reveals hypermethylation and overexpression of HOX genes to be poor prognosticators in isocitrate dehydrogenase mutant glioma. | Neuro Oncol | 2023 |
| 36513065 | Clinically oriented prediction of patient response to targeted and immunotherapies from the tumor transcriptome. | Med | 2023 |
| 36964296 | Pediatric-type high-grade neuroepithelial tumors with CIC gene fusion share a common DNA methylation signature. | NPJ Precis Oncol | 2023 |
| 37075315 | An unusual case of metastatic diffuse midline glioma in an adult. | J Neuropathol Exp Neurol | 2023 |
| 36759899 | Common molecular features of H3K27M DMGs and PFA ependymomas map to hindbrain developmental pathways. | Acta Neuropathol Commun | 2023 |
| 36490308 | A 64-year-old woman with frontal lobe lesion and drug-resistant epilepsy. | Brain Pathol | 2023 |
| 37004911 | Distinguishing Gastric/Esophageal Adenocarcinoma from Pancreatic Adenocarcinoma Using Methylation-Based Droplet Digital PCR. | Lab Invest | 2023 |
| 37316351 | Single-cell methylation sequencing data reveal succinct metastatic migration histories and tumor progression models. | Genome Res | 2023 |
| 37188783 | Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial. | Nat Med | 2023 |
| 37119018 | Atypical neurofibromatous lesions: Epigenetic cousins of other benign peripheral nerve sheath tumors? | Neuro Oncol | 2023 |
| 36802047 | Molecular classification and grading of meningioma. | J Neurooncol | 2023 |
| 36741001 | Heterogeneous clinicopathological findings and patient-reported outcomes in adults with <i>MN1</i>-altered CNS tumors: A case report and systematic literature review. | Front Oncol | 2023 |
| 36933012 | Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions. | Acta Neuropathol | 2023 |
| 37432627 | The Epigenetic Landscape of Meningiomas. | Adv Exp Med Biol | 2023 |
| 37171636 | Correction: Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas. | Acta Neuropathol | 2023 |
| 36732531 | Estimation of cell lineages in tumors from spatial transcriptomics data. | Nat Commun | 2023 |
| 37164978 | Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities. | Nat Commun | 2023 |
| 36720866 | Author Correction: Astroblastomas exhibit radial glia stem cell lineages and differential expression of imprinted and X-inactivation escape genes. | Nat Commun | 2023 |
| 38026572 | Reference on copy number variations in pleomorphic xanthoastrocytoma: Implications for diagnostic approach. | Free Neuropathol | 2023 |
| 37953374 | Pseudoendocrine sarcoma: clinicopathologic, molecular, and epigenetic features of one case. | Virchows Arch | 2023 |
| 37851269 | Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations. | Acta Neuropathol | 2023 |
| 37790315 | Prediction of cancer treatment response from histopathology images through imputed transcriptomics. | Res Sq | 2023 |
| 37742132 | A novel ARIH1::BRAF fusion in a glioma. | J Neuropathol Exp Neurol | 2023 |
| 35849035 | Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial. | Neuro Oncol | 2023 |
| 37218333 | ZFTA-fused supratentorial ependymoma with a novel fusion partner, DUX4. | J Neuropathol Exp Neurol | 2023 |
| 37188783 | Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial. | Nat Med | 2023 |
| 37287579 | Introduction: Ongoing clinical challenges in the management of meningiomas and future directions. | Neurooncol Adv | 2023 |
| 37119018 | Atypical neurofibromatous lesions: Epigenetic cousins of other benign peripheral nerve sheath tumors? | Neuro Oncol | 2023 |